15Jun

[Editorial] Difficult choices in treating Parkinson’s disease psychosis

Around half of all patients with advanced Parkinson's disease will develop hallucinations or delusions. Treatments for Parkinson's disease psychosis are scarce, in part because many antipsychotics are known to worsen motor symptoms, or are not effective. In 2016, pimavanserin became the first antipsychotic to be recommended by the US Food and Drug Administration (FDA) for the treatment of Parkinson's disease psychosis. Since then, there have been numerous reports of serious adverse events, including deaths.

Ander nieuws

20May

[Comment] A new step towards targeting tau

Progressive supranuclear palsy is a rare neurodegenerative disease characterised by an axial parkins...

naar nieuwsitem

20May

[Review] CSF and blood biomarkers for Parkinson’s disease

In the management of Parkinson's disease, reliable diagnostic and prognostic biomarkers are urg...

naar nieuwsitem

22Apr

Parkinson’s disease patient: ‘I can walk… it’s really helped me’

Parkinson's disease patient Gail Jardine can walk more freely after having a spinal implant fit...

naar nieuwsitem